Spansules Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.90 Cr
as on 03-07-2024
- Revenue -34.61%
(FY 2022)
- Profit -1475.93%
(FY 2022)
- Ebitda -1176.01%
(FY 2022)
- Net Worth -335.85%
(FY 2022)
- Total Assets 50.01%
(FY 2022)
About Spansules Formulations
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.90 Cr.
Rama Guttikonda and Haswanth Guttikonda serve as directors at the Company.
- CIN/LLPIN
U33110TG2015PTC098644
- Company No.
098644
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Spansules Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Haswanth Guttikonda  | Director | 24-Apr-2015 | Current |
| Rama Guttikonda | Director | 24-Apr-2015 | Current |
Financial of Spansules Formulations.
Spansules Formulations Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 34.61% decrease. The company also saw a substantial fall in profitability, with a 1475.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 335.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spansules Formulations?
In 2022, Spansules Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spansules Pharmatech Private LimitedActive 24 years 2 monthsRama Guttikonda and Haswanth Guttikonda are mutual person
Spansules Formulations India Private LimitedActive 2 years 9 monthsRama Guttikonda and Haswanth Guttikonda are mutual person
- Spansules Life Sciences Private LimitedActive 3 years 3 months
Rama Guttikonda and Haswanth Guttikonda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Jul 2023 | ₹9.90 Cr | Open |
How Many Employees Work at Spansules Formulations?
Unlock and access historical data on people associated with Spansules Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spansules Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spansules Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
